← FDA Drug Approvals (Drugs@FDA)
EMCITATE
NDA · New Drug Application · Sponsor: RARE THYROID THERAPEUTICS INTERNATIONAL AB · Approved 2026-09-28
Drug application
- FDA Application #
NDA220963- Application type
- New Drug Application
- Brand name
- EMCITATE
- Generic name
- Tiratricol
- Active ingredients
- TIRATRICOL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- RARE THYROID THERAPEUTICS INTERNATIONAL AB
- First approval
- 2026-09-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown